CapsoVision, Inc. (CV) Income Statement

NASDAQ: CVRevenue, profits, margins and EPS over 3 years.

CV 2025 at a glance

Fiscal year ended December 31, 2025 · U.S. dollars
Revenue+15.3%
$13.6M
2025 · hover or tap a bar for each year
2023: $9.8M2024: $11.8M (+20.5%)2025: $13.6M (+15.3%)
20232025
Gross profit+12.5%
$7.2M
2025 · hover or tap a bar for each year
2023: $5.5M2024: $6.4M (+16.1%)2025: $7.2M (+12.5%)
20232025
Operating income
−$25.5M
2025 · hover or tap a bar for each year
2023: −$11.3M2024: −$19.9M2025: −$25.5M
20232025
Net income
−$25.3M
2025 · hover or tap a bar for each year
2023: −$11.3M2024: −$19.9M2025: −$25.3M
20232025
EPS (diluted)
−$2.92
2025 · hover or tap a bar for each year
2024: −$0.432025: −$2.92
20232025
Net profit margin−17.5 pts
−186.8%
2025 · hover or tap a point for each year
2023: −115.9%2024: −169.3% (−53.3 pts)2025: −186.8% (−17.5 pts)
20232025

CV revenue and net income

RevenueNet incomeNet margin (right axis)

Where CV's revenue goes

2025
Revenue
$13.6M100.0%
Cost of revenue
−$6.4M−47.1%
Gross profit
$7.2M52.9%
Research & development
−$18.3M−135.1%
Sales, general & admin
−$14.4M−106.1%
Operating income
−$25.5M−188.3%
Interest & other income
$225,0001.7%
Net income
−$25.3M−186.8%

Each bar shows an amount and its share of revenue. CV kept −186.8% of revenue as net income.

CV profit margins

GrossOperatingNet

CV growth rates

to 2025
1 year3 years5 years10 years
Revenue+15.3%———
Gross profit+12.5%———
Operating income————
Net income————
EPS (diluted)————

1-year change and average annual growth (CAGR) over 3, 5 and 10 fiscal years. "—" when a starting value was zero or negative.

CV quarterly EPS vs estimates

Reported EPSAnalyst estimate

CapsoVision beat the analyst EPS estimate in 1 of the last 6 quarters. Next report: November 12, 2026 (estimate $-0.15).

CV income statement

CapsoVision, Inc. annual income statement
202520242023
Revenue$13.6M$11.8M$9.8M
Cost of revenue$6.4M$5.4M$4.3M
Gross profit$7.2M$6.4M$5.5M
Research & development$18.3M$15.1M$9.3M
Sales, general & admin$14.4M$11.2M$7.5M
Total operating expenses$32.7M$26.3M$16.8M
Operating income−$25.5M−$19.9M−$11.3M
Interest income$269,000$26,000$49,000
Income before taxes−$25.3M−$19.9M−$11.3M
Income taxes$24,000$11,000$11,000
Net income−$25.3M−$19.9M−$11.3M
EBITDA−$24.9M−$19.4M−$11.0M
EPS (diluted)−$2.92−$0.43—
Gross margin52.9%54.2%56.3%
Operating margin−188.3%−169.4%−116.3%
Net margin−186.8%−169.3%−115.9%

Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported in CV's financial statements (latest annual report filed March 26, 2026); data from EODHD. Sales, general & administrative expenses include sales and marketing.

CV financial results

In fiscal year 2025 (ended December 31, 2025), CapsoVision reported revenue of $13.6 million, up 15.3% from the year before. It had a net loss of $25.3 million, a net profit margin of −186.8%. Diluted earnings per share came to −$2.92.

See the CV stock overview for the latest quote and news, or the CV chart for price history and technical indicators.

CV income statement FAQ

What is CapsoVision's annual revenue?

CapsoVision reported total revenue of $13.6 million for fiscal year 2025, which ended on December 31, 2025. That was up 15.3% from $11.8 million the previous year.

Is CapsoVision profitable?

No. CapsoVision reported a net loss of $25.3 million in fiscal 2025, a net profit margin of −186.8%; its operating margin was −188.3%.

What is CapsoVision's gross margin?

CapsoVision's gross margin was 52.9% in fiscal 2025: for every $100 of revenue, CapsoVision kept $53 after the direct cost of its products and services.

How much does CapsoVision spend on research and development?

CapsoVision spent $18.3 million on research and development in fiscal 2025, 135.1% of revenue.

What are CapsoVision's earnings per share?

CapsoVision earned $-2.92 per diluted share in fiscal 2025, compared with $-0.43 a year earlier.

When will CapsoVision report its next earnings?

CapsoVision is expected to report results for the quarter ending September 30, 2026 on November 12, 2026 after the market closes.

When does CapsoVision's fiscal year end?

CapsoVision's fiscal year ends in December. The latest annual report covers the year ended December 31, 2025 and was filed on March 26, 2026.

Medical Devices income statements